Hangzhou Meiya pharmaceutical Co.Ltd. is a bio-pharmaceutical enterprise specialized in nucloetides manufacturing ,and owns self-support right of import and export. Products include Nucleoside, NMP, NDP, NTP,Polynucleotide series and Cyclic nucleotide series, which provide application solutions for medicine, dietary supplement, animal health & diagnostic reagent.
more >
Year of Establishment:
1998
Total Assets(USD):
5,000,000 to 5,999,999
Total Number of Staff:
60 to 69
Main Competitive Advantages:
Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Quality Service
Other Competitive Advantages:
Specialized in manufacturing nucleotides.
Patents and Copyrights:
Calcium dibutyryl adenosine cyclophosphate
Business Type:
Manufacturer
R&D capacity:
Annual Turnover(USD):
15,000,000 to 19,999,999
Main Sales Markets:
North America,Central/South America,Eastern Europe,Asia,Middle East,Africa
Other Competitive Advantages:
Specialized in manufacturing nucleotides.
Patents and Copyrights:
Calcium dibutyryl adenosine cyclophosphate